CCACX
Price
$23.95
Change
-$0.21 (-0.87%)
Updated
Nov 14 closing price
FSMDX
Price
$35.72
Change
-$0.33 (-0.92%)
Updated
Nov 14 closing price
Ad is loading...

CCACX vs FSMDX

Header iconCCACX vs FSMDX Comparison
Open Charts CCACX vs FSMDXBanner chart's image
Calvert Mid-Cap C
Price$23.95
Change-$0.21 (-0.87%)
VolumeN/A
CapitalizationN/A
Fidelity Mid Cap Index
Price$35.72
Change-$0.33 (-0.92%)
VolumeN/A
CapitalizationN/A
CCACX vs FSMDX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CCACX vs. FSMDX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCACX is a StrongBuy and FSMDX is a Buy.

FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 36.3B vs. CCACX (225M). FSMDX pays higher dividends than CCACX: FSMDX (1.28) vs CCACX (0.00). CCACX was incepted earlier than FSMDX: CCACX (30 years) vs FSMDX (13 years). CCACX is a more actively managed with annual turnover of: 27.00 vs. FSMDX (9.00). FSMDX has a lower initial minimum investment than CCACX: FSMDX (0) vs CCACX (1000). FSMDX annual gain was more profitable for investors over the last year : 33.08 vs. CCACX (21.76). FSMDX return over 5 years is better than : 62.77 vs. CCACX (-0.58).
CCACXFSMDXCCACX / FSMDX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years13 years-
Gain YTD13.84820.41368%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets225M36.3B1%
Annual Yield % from dividends0.001.28-
Returns for 1 year21.7633.0866%
Returns for 3 years-17.4811.57-151%
Returns for 5 years-0.5862.77-1%
Returns for 10 years-22.36126.10-18%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOPA0.93N/A
+0.01%
Society Pass Incorporated
BCH22.96-0.16
-0.69%
Banco de ChileAmerican
EP6.27-0.12
-1.88%
Empire Petroleum Corp
PRCT92.25-3.30
-3.45%
PROCEPT BioRobotics Corp
ATXS10.63-0.53
-4.75%
Astria Therapeutics